Overview / Abstract: |
Since the advent of the first treatment for relapsing-remitting multiple sclerosis more than 2 decades ago, considerable changes have altered management approaches. In recent decades, the goals of treatment for MS have generally shifted from reducing the frequency and severity of relapses and delaying progression to preventing new or enhancing lesions on magnetic resonance imaging and reducing brain atrophy. Healthcare providers increasingly rely on coordination of care and systems-based strategies to manage MS in patients who have a suboptimal response to therapy. Goals (Purpose) of Program |
Expiration |
Sep 12, 2018 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Online |
Credits / Hours |
0.5 contact hours |
Accreditation |
ACCME, ANCC |
Presenters / Authors / Faculty |
Edward Fox, MD, PhD Director, Multiple Sclerosis Clinic Lori Mayer, DNP, MSN, RN, MSCN |
Sponsors / Supporters / Grant Providers |
Genentech, Inc. |
Keywords / Search Terms |
CMEology CMEology Neurology, disease-modifying therapies, DMTs, MS, Multiple Sclerosis, physicians, CME, Continuing Education, Continuing medical education, nursing, MS pathophysiology, Free CE CME Free CE CME |